Search Results 31-40 of 28833 for Lupus

  1. A Study of CC-97540 in Participants With Severe, Refractory Systemic Lupus Erythematosus (SLE) - Mayo Clinic

    ... Lupus Erythematosus, and to determine the RP2D(s) of CC-97540 in participants with severe, refractory Systemic Lupus Erythematosus (SLE). Participation ...

  2. Aurinia Renal Response in Active Lupus With Voclosporin - Mayo Clinic

    ... lupus nephritis. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  3. Mixed connective tissue disease - Symptoms & causes - Mayo Clinic

    Mixed connective tissue disease (MCTD) has signs and symptoms of a combination of disorders — primarily lupus, scleroderma, and polymyositis. Many people ...

  4. Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus - Mayo Clinic

    About this study. This is a multi-center, double-blind, randomized, Phase 2b trial to evaluate the efficacy of atacicept in subjects with systemic lupus ...

  5. Consumer Health: What do you know about rheumatic diseases? - Mayo Clinic News Network

    ... Lupus. Lupus is an autoimmune disease that occurs when your body's immune system attacks your tissues and organs. Inflammation caused by lupus can affect ...

  6. Mayo Rheumatologist Dr. Timothy Niewold Recognized for Achievements in Lupus Research

    Timothy Niewold has received the Lupus Foundation of America's Mary Betty Stevens Young Investigator Prize for his research on the autoimmune disease lupus. Dr.

  7. Daratumumab to Treat Active Lupus Nephritis - Mayo Clinic

    ... lupus nephritis (LN) as measured by change in proteinuria and serum creatinine. Participation eligibility. Participant eligibility includes age, gender, type ...

  8. Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus - Mayo Clinic

    The purpose of this study is to investigate the role of nailfold capillaroscopy in the assessment of patients with Systemic Lupus Erythematosus (SLE).

  9. Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V - Mayo Clinic

    Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V · Overview · Participation eligibility · Participating Mayo ...

  10. A Study of the Safety and Tolerability of JNJ-55920839, Either as a Single Ascending Dose in Healthy Individuals or as Multiple Doses for Patients who have Mild to Moderate Systemic Lupus Erythematosus - Mayo Clinic

    ... Lupus International Collaborating Clinics (SLICC) criteria for diagnosis of lupus ... Has active Central nervous system (CNS) lupus or history of severe CNS lupus ...